Novel insights into the pathogenesis and treatment of NRAS mutant melanoma
{{output}}
Introduction: NRAS was the first mutated oncogene identified in melanoma and is currently the second most common driver mutation in this malignancy. For patients with NRASmutant advanced stage melanoma refractory to immunotherapy... ...
